Literature DB >> 19808352

Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.

Gerhard Poelzl1, Christian Eberl, Helene Achrainer, Jakob Doerler, Otmar Pachinger, Matthias Frick, Hanno Ulmer.   

Abstract

BACKGROUND: Serum gamma-glutamyltransferase (GGT) is associated with incident cardiovascular diseases and is a potential risk factor for disease mortality. We investigated the relevance of circulating GGT in chronic heart failure. METHODS AND
RESULTS: From 2000 to 2007 clinical and laboratory variables of 1033 consecutive outdoor patients with heart failure were evaluated. Follow-up (mean, 34.4 months) was available in 998 patients. The end point was defined as death from any cause or heart transplantation. A forward stepwise Cox proportional hazards regression model for sex-stratified data was used. Prevalence of elevated GGT was 42.9% in men (GGT >65 U/L) and 50.2% in women (GGT >38 U/L), which was higher than for sex- and age-matched healthy subjects (18.6% in men, 19.2% in women) derived from a large historical control group. GGT was associated with severity of heart failure as assessed by New York Heart Association class, left-ventricular ejection fraction, and amino-terminal pro-B-type natriuretic peptide. The end point was recorded in 302 patients. Compared with the lowest GGT quintile, sex-stratified hazard ratios for patients in the highest quintile were 2.88 (1.99 to 4.17) in the univariate model and 1.87 (1.28 to 2.74) in the adjusted model (P<0.001). Corresponding 5-year cumulative event rates were 47% and 74%, respectively. Adjusted hazard ratios for elevated GGT was 2.9 (1.64 to 5.17) for patients in New York Heart Association I/II, and 1.2 (0.75 to 2.05) for patients in New York Heart Association III/IV, respectively (P=0.003, for the GGT-New York Heart Association class interaction).
CONCLUSIONS: Prevalence of elevated GGT is high in patients with chronic heart failure. The GGT levels are associated with disease severity. Increased GGT is an independent predictor of death or heart transplantation. GGT may provide additional prognostic information, especially in patients with mild heart failure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19808352     DOI: 10.1161/CIRCHEARTFAILURE.108.826735

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  17 in total

Review 1.  Cardiohepatic syndrome.

Authors:  Gerhard Poelzl; Johann Auer
Journal:  Curr Heart Fail Rep       Date:  2015-02

2.  Serum gamma-glutamyl transferase and risk of heart failure in the community.

Authors:  Ravi Dhingra; Philimon Gona; Thomas J Wang; Caroline S Fox; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-06-10       Impact factor: 8.311

3.  Liver diseases in heart failure.

Authors:  Majid Maleki; Farveh Vakilian; Ahmad Amin
Journal:  Heart Asia       Date:  2011-01-01

4.  Elevated γ-glutamyltransferase in implantable cardioverter defibrillator patients.

Authors:  Wolfgang Dichtl; Thomas Wolber; Ursula Paoli; Thomas Theurl; Simon Brüllmann; Markus Stühlinger; Thomas Berger; Karin Spuller; Alexander Strasak; Otmar Pachinger; Laurent Haegeli; Firat Duru; Florian Hintringer
Journal:  Wien Klin Wochenschr       Date:  2011-09-02       Impact factor: 1.704

5.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

Review 6.  Role of gamma-glutamyltransferase in cardiovascular diseases.

Authors:  Shengyang Jiang; Donglin Jiang; Yijia Tao
Journal:  Exp Clin Cardiol       Date:  2013

7.  Plasma amino acid profiling identifies specific amino acid associations with cardiovascular function in patients with systolic heart failure.

Authors:  Daihiko Hakuno; Yasuhito Hamba; Takumi Toya; Takeshi Adachi
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

8.  Nonalcoholic Fatty Liver Disease Is Associated With Higher 1-year All-Cause Rehospitalization Rates in Patients Admitted for Acute Heart Failure.

Authors:  Filippo Valbusa; Stefano Bonapace; Cristina Grillo; Luca Scala; Andrea Chiampan; Andrea Rossi; Giacomo Zoppini; Amedeo Lonardo; Guido Arcaro; Christopher D Byrne; Giovanni Targher
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

9.  Association of γ-glutamyl transferase with premature coronary artery disease.

Authors:  Madankumar Ghatge; Ankit Sharma; Rajani Kanth Vangala
Journal:  Biomed Rep       Date:  2016-01-21

10.  Liver Congestion Assessed by Hepatic Vein Waveforms in Patients With Heart Failure.

Authors:  Yukiko Sugawara; Akiomi Yoshihisa; Shinji Ishibashi; Mitsuko Matsuda; Yukio Yamadera; Himika Ohara; Yasuhiro Ichijo; Koichiro Watanabe; Yu Hotsuki; Fumiya Anzai; Yu Sato; Yusuke Kimishima; Tetsuro Yokokawa; Tomofumi Misaka; Shinya Yamada; Takamasa Sato; Takashi Kaneshiro; Masayoshi Oikawa; Atsushi Kobayashi; Yasuchika Takeishi
Journal:  CJC Open       Date:  2021-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.